Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.2K Sell
13,760
-2,073
-13% -$5.92K ﹤0.01% 662
2025
Q4
$39.1K Buy
15,833
+746
+5% +$1.78K ﹤0.01% 611
2025
Q3
$33.6K Buy
+15,087
New +$34.5K ﹤0.01% 860

Other funds holding ABEV

NorthRock Partners's ABEV Position: Q1 2026 in Review

NorthRock Partners reduced its Ambev (ABEV) stake by 13% in Q1 2026, selling an estimated $5.92K and leaving 13,760 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #662.

NorthRock Partners first reported a position in ABEV in Q3 2025 and has held it in 3 quarters since. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • NorthRock Partners held 13,760 shares of Ambev worth $40.2K as of Q1 2026.
  • NorthRock Partners sold 2,073 Ambev shares in Q1 2026, an estimated $5.92K.
  • Ambev made up ﹤0.01% of NorthRock Partners's portfolio in Q1 2026, its #662 holding.
  • NorthRock Partners first reported a position in Ambev in Q3 2025 and has held it in 3 quarters since.
  • 402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.